CSIMarket


Apogee Therapeutics inc   (APGE)
Other Ticker:  
 


 

Apogee Therapeutics inc

APGE's Financial Statements and Analysis



Apogee Therapeutics inc reported in the first quarter of 2024 net loss per share of $-0.64 compare to earnings per share of $0.00 in the same quarter a year ago a decrease compare to $-0.51 realized in previous quarter.


first quarter of 2024
Earnings Per Share Revenues
$ -0.64 $  0 Mill
$-0.64     Unch.    



Apogee Therapeutics Inc 's Revenue rose by 0 % in first quarter of 2024 (Mar 31 2024) year on year, to $0 million and declined by sequentially.


Apogee Therapeutics Inc is Expected to report next financial results on August 27, 2024.

More on APGE's Income Statement



Apogee Therapeutics Inc in the first quarter of 2024 recorded net loss of $-32.094 million, a decrease compare to net income of $0.000 million achieved in a year ago.

Sequentially net loss advanced

More on APGE's Growth

Apogee Therapeutics Inc Inventories
APGE's Cash flow In the first quarter of 2024 company's net cash flow was $367 million

More on APGE's Cash flow Statement


Apogee Therapeutics inc does not pay out common stock dividend.

In trailing twelve-month period Apogee Therapeutics inc payed $ -1.53 cash per share, on a free-cash flow basis .


Tangible Book value fell to $ 0.00 per share from $ 0.00.

Company issued 8.96 million shares or 21.73 % in Mar 31 2024.


More on APGE's Dividends

 Market Capitalization (Millions) 2,402
 Shares Outstanding (Millions) 50
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -72
 Cash Flow (TTM) (Millions $) 404
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Apogee Therapeutics inc does not pay out common stock dividend.

In trailing twelve-month period Apogee Therapeutics inc had negative $ -1.53 cash flow per share, on a free-cash flow basis .


Tangible Book value fell to $ 0.00 per share from $ 0.00.

Company issued 8.96 million shares or 21.73 % in Mar 31 2024.


More on APGE's Balance Sheets

 Market Capitalization (Millions) 2,402
 Shares Outstanding (Millions) 50
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -72
 Cash Flow (TTM) (Millions $) 404
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -
   


  News about Apogee Therapeutics inc Earnings